Results 81 to 90 of about 162,637 (248)
Impact of delayed appointments on treatment outcomes in neovascular macular degeneration
Abstract Purpose To evaluate the real‐world visual outcomes of anti‐vascular endothelial growth factor (anti‐VEGF) therapy, the frequency of delayed appointments and the relationship between delays and visual outcomes in patients with neovascular age‐related macular degeneration (nAMD).
Petri Purola +3 more
wiley +1 more source
Embryonic Intravitreous Injection in Mouse
Axons of retinal ganglion cells (RGCs) relay visual information from the retina to lateral geniculate nucleus (LGN) and superior colliculus (SC), which are two major image-forming visual nuclei. Wiring of these retinal projections completes before vision begins.
Liyuan Cui, Yupu Diao, Jiayi Zhang
openaire +4 more sources
A new model for management of intravitreal injections: Bari Policlinico real world experience
Purpose: Worldwide real-world data showed that the letters gain was much lower than pivotal trials. This gap can have many reasons, including the onset of intravitreal therapy was too late both for delay in diagnosis and for long waiting list; the number
MARIA OLIVA, Grassi
core
Abstract Introduction The increasing number of patients with diabetes has increased the incidence of diabetic macular oedema (DME) with the accompanying risk of developing visual loss. The purpose of the present study was to describe the contributions of increased central retinal thickness (CRT) and other risk factors to the reduction in visual acuity ...
Signe Krejberg Jeppesen, Toke Bek
wiley +1 more source
There are two forms of age-related macular degeneration (AMD), the dry one and the exudative one. The exudative form of AMD can be treated using repeated intravitreal injections of antibodies against vascular endothelial growth factor (VEGF).
Michał Biskup +2 more
core +1 more source
Abstract Purpose Retinal telangiectatic capillaries (TelCaps) are microvascular abnormalities associated with chronic vascular macular oedema and suboptimal response to intravitreal therapy. Targeted laser photocoagulation is beneficial but requires precise localization using indocyanine green angiography (ICG‐A), the reference standard. However, ICG‐A
Lucas Unger +7 more
wiley +1 more source
Dimitrios Karagiannis,1 Georgios A Kontadakis,1,2 Konstantinos Kaprinis,1 Athanassios Giarmoukakis,2 lias Georgalas,3 Efstratios A Parikakis,1 Miltiadis K Tsilimbaris2 1Ophthalmiatreio Eye Hospital of Athens, Athens, Greece; 2Department of Ophthalmology,
Kontadakis GA +6 more
core
Endophthalmitis After Intravitreal Injections
Endophthalmitis after intravitreal injections is a rare but devastating complication of this common eye procedure. Patients typically present within 5 days of their injection with decreased vision, pain, and redness.
John B. Miller +5 more
core +1 more source
Abstract Purpose To evaluate changes in the prevalence and incidence of type 2 diabetes, the association between type 2 diabetes and diabetic retinopathy (DR), and the impact of type 2 diabetes and DR on visual acuity (VA) in Finland during 2000–2017. Methods We used three nationwide health examination surveys conducted in 2000, 2011 and 2017, with a ...
Petri Purola +4 more
wiley +1 more source
Clinical outcomes of the PAUL® glaucoma implant for secondary glaucoma
Abstract Purpose Secondary glaucoma encompasses a broad spectrum of disease entities arising from diverse ocular pathologies and is often refractory to conventional treatment. Glaucoma drainage devices (GDDs) have therefore become an important surgical option.
Carolin Deubel +7 more
wiley +1 more source

